Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pediatric Asthma Clinical Effectiveness study (PEACE)
2015-004898-32Phase 3
- Sponsor
- GSK
- Start
- Dec 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in asthma comparing Salmeterol + fluticasone propionate (DISKUS) with Montelukast 5 mg chewable tablets (2 arms). Primary endpoint: Change in mean morning peak expiratory flow over weeks 1–12.
02
Drugs
salmeterolfluticasone propionatemontelukast
03
Conditions
asthma
Beyond the preview
Go deeper on 2015-004898-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004898-32.